The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation.
Open accessAbstract
The migration of vascular smooth muscle cells (VSMCs) from the tunica media to the neointima is a key event in the development and progression of many vascular diseases and a highly predictable consequence of mechanical injury to the blood vessel. In vivo, VSMCs are surrounded by and embedded in a variety of extracellular matrices (ECMs) that must be traversed during migration. One of the principal barriers to cell movement in the intact vessel is the basement membrane (BM) that surrounds each VSMC and separates the VSMC-containing medial cell layer from the endothelium. We have used a Boyden chamber to monitor the ability of VSMCs to degrade a BM barrier as they migrate toward a chemoattractant and to define the role of extracellular proteases in this process. We show that cultured VSMCs can migrate across a BM barrier and that this ability was dependent on the phenotypic state of the cell. VSMCs maintained in a proliferating or "synthetic" state readily migrated across a BM toward a chemoattractant, whereas the migration of serum-starved/differentiated VSMCs was suppressed by > 80% (P < .001). By use of a number of peptides that inhibit matrix metalloproteinase (MMP) activity, the migration of proliferating VSMCs across the BM barrier was inhibited by > 80% (P < .0001), whereas migration that occurred in the absence of the barrier was unaffected. Northern blotting and zymographic analyses indicated that 72-kD type IV collagenase (MMP2) was the principal MMP expressed and secreted by these cells. Accordingly, antisera capable of selectively neutralizing MMP2 activity also inhibited VSMC migration across the barrier without significantly affecting the migration of VSMCs in the absence of the barrier. Finally, MMP2 activity was also regulated by the phenotypic state of the cells in that MMP2 activity expressed by serum-starved/differentiated VSMCs was < 5% of that measured in proliferating VSMCs. Extrapolating to the in vivo situation in which VSMCs reside in an ECM composed of various BM barriers, these results suggest that VSMC migration in vivo may be dependent on MMP2 activity. That activity, in turn, could be regulated by the phenotypic state of VSMCs and increase as these cells undergo the transition from a quiescent and differentiated state to that of a dedifferentiated, proliferating, and motile phenotype after injury to the vessel.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302
Molecular cloning: A laboratory manual
Deininger, P. (1990) · Analytical Biochemistry · doi:10.1016/0003-2697(90)90595-z · Cited by 84,682
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease
Chirgwin, J. M., Przybyla, A. E., MacDonald, R. J., & Rutter, W. J. (1979) · Biochemistry · doi:10.1021/bi00591a005 · Cited by 21,725
The pathogenesis of atherosclerosis: a perspective for the 1990s
Ross, R. (1993) · Nature · doi:10.1038/362801a0 · Cited by 10,630
The Pathogenesis of Atherosclerosis — An Update
Ross, R. (1986) · New England Journal of Medicine · doi:10.1056/nejm198602203140806 · Cited by 4,877
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
Liotta, L. A., Steeg, P. S., & Stetler-Stevenson, W. G. (1991) · Cell · doi:10.1016/0092-8674(91)90642-c · Cited by 2,720
Plasminogen Activators, Tissue Degradation, and Cancer
(1985) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60028-7 · Cited by 2,535
Fort, P., Marty, L., Piechaczyk, M., Sabrouty, S. E., Dani, C., Jeanteur, P., & Blanchard, J. M. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.5.1431 · Cited by 2,099
Heussen, C., & Dowdle, E. B. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90338-3 · Cited by 1,973
A rapid in vitro assay for quantitating the invasive potential of tumor cells.
Albini, A., Iwamoto, Y., Hk, K., Gr, M., Aaronson, S. A., Jm, K., & McEwan, R. N. (1987) · PubMed · Cited by 1,778
Metalloproteinases and their inhibitors in matrix remodeling
Matrisian, L. M. (1990) · Trends in Genetics · doi:10.1016/0168-9525(90)90126-q · Cited by 1,605
Basement membrane complexes with biological activity
Kleinman, H. K., McGarvey, M. L., Hassell, J. R., Star, V. L., Cannon, F. B., Laurie, G. W., & Martin, G. R. (1986) · Biochemistry · doi:10.1021/bi00350a005 · Cited by 1,502
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Wilhelm, S. M., Collier, I. E., Marmer, B. L., Eisen, A. Z., Grant, G. A., & Goldberg, G. I. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)71480-4 · Cited by 1,109
Inhibition of Neointimal Smooth Muscle Accumulation After Angioplasty by an Antibody to PDGF
Ferns, G. A. A., Raines, E. W., Sprugel, K. H., Motani, A. S., Reidy, M. A., & Ross, R. (1991) · Science · doi:10.1126/science.1653454 · Cited by 1,065
Collier, I. E., Wilhelm, S. M., Eisen, A. Z., Marmer, B. L., Grant, G. A., Seltzer, J. L., Kronberger, A., He, C. S., Bauer, E. A., & Goldberg, G. I. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)68680-6 · Cited by 1,044
Suppression by heparin of smooth muscle cell proliferation in injured arteries
CLOWES, A. W., & KARNOWSKY, M. J. (1977) · Nature · doi:10.1038/265625a0 · Cited by 790
Replication of smooth muscle cells in vascular disease.
Schwartz, S. M., Campbell, G. R., & Campbell, J. H. (1986) · Circulation Research · doi:10.1161/01.res.58.4.427 · Cited by 759
Tumor invasion through the human amniotic membrane: Requirement for a proteinase cascade
Mignatti, P., Robbins, E., & Rifkin, D. B. (1986) · Cell · doi:10.1016/0092-8674(86)90613-6 · Cited by 746
92-kD type IV collagenase mediates invasion of human cytotrophoblasts.
Librach, C. L., Werb, Z., Fitzgerald, M. L., Chiu, K., Corwin, N. M., Esteves, R. A., Grobelny, D., Galardy, R., Damsky, C. H., & Fisher, S. J. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.2.437 · Cited by 720
Jawien, A., Bowen-Pope, D. F., Lindner, V, Schwartz, S. M., & Clowes, A. W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115613 · Cited by 674
Grotendorst, G. R., Seppä, H. E., Kleinman, H. K., & Martin, G. R. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.6.3669 · Cited by 504
Type IV collagenases in tumor invasion and metastasis
Stetler-Stevenson, W. G. (1990) · CANCER AND METASTASIS REVIEW · doi:10.1007/bf00049520 · Cited by 502
Identification of an Inhibitor of Neovascularization from Cartilage
Moses, M. A., Sudhalter, J., & Langer, R. (1990) · Science · doi:10.1126/science.1694043 · Cited by 477
Stetler-Stevenson, W. G., Brown, P. D., Onisto, M., Levy, A. T., & Liotta, L. A. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)77438-3 · Cited by 422
Fingerle, J., Johnson, R., Clowes, A. W., Majesky, M. W., & Reidy, M. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.21.8412 · Cited by 414
Re-Stenosis after Successful Coronary Angioplasty
McBride, W., Lange, R. A., & Hillis, L. D. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806303182606 · Cited by 403
Clowes, A. W., Clowes, M. M., Au, Y. P., Reidy, M. A., & Belin, D. (1990) · Circulation Research · doi:10.1161/01.res.67.1.61 · Cited by 333
Human vascular smooth muscle cells. Target for and source of tumor necrosis factor.
Warner, S. J., & Libby, P. (1989) · The Journal of Immunology · doi:10.4049/jimmunol.142.1.100 · Cited by 328
What controls smooth muscle phenotype?
Chamley-Campbell, J. H., & Campbell, G. R. (1981) · Atherosclerosis · doi:10.1016/0021-9150(81)90145-3 · Cited by 320
Control of Growth and Differentiation of Vascular Cells by Extracellular Matrix Proteins
Carey, D. J. (1991) · Annual Review of Physiology · doi:10.1146/annurev.ph.53.030191.001113 · Cited by 207
Shapiro, S. D., Griffin, G. L., Gilbert, D. J., Jenkins, N. A., Copeland, N. G., Welgus, H. G., Senior, R. M., & Ley, T. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42885-2 · Cited by 204
Myosin heavy chain isoform diversity in smooth muscle is produced by differential RNA processing
Babij, P., & Periasamy, M. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90142-3 · Cited by 185
Bell, L. B., & Madri, J. A. (1989) · Circulation Research · doi:10.1161/01.res.65.4.1057 · Cited by 131
Sequences coding for part of oncogene-induced transin are highly conserved in a related rat gene
Breathnach, R., Matrisian, L. M., Gesnel, M.-C., Staub, A., & Leroy, P. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.3.1139 · Cited by 128
Blank, R. S., Thompson, M. M., & Owens, G. K. (1988) · The Journal of Cell Biology · doi:10.1083/jcb.107.1.299 · Cited by 113
YANAGI, H., SASAGURI, Y., Sugama, K., MORLMATSU, M., & Nagase, H. (1991) · Atherosclerosis · doi:10.1016/0021-9150(91)90168-3 · Cited by 104
Experimental models that mimic the differentiation and dedifferentiation of vascular cells.
Rr, P., Passaniti, A., Crow, M. T., Jl, K., Papadopoulos, N. M., Monticone, R. E., Lakatta, E. G., & Gr, M. (1992) · PubMed · Cited by 95
Self-citationLoppnow, H., & Libby, P. (1992) · Experimental Cell Research · doi:10.1016/0014-4827(92)90381-h · Cited by 86
Melchiori, A., Albini, A., Ray, J., & Stetler‐Stevenson, W. G. (1992) · PubMed · Cited by 85
Mackay, A. R., Gomez, D. E., Cottam, D. W., Rees, R. C., Am, N., & Thorgeirsson, U. P. (1993) · PubMed · Cited by 55
Polypeptide growth factors and atherosclerosis
Ross, R. (1991) · Trends in Cardiovascular Medicine · doi:10.1016/1050-1738(91)90043-e · Cited by 43
Cited by
Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G., & Galis, Z. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119076 · Cited by 1,141
Lakatta, E. G. (2003) · Circulation · doi:10.1161/01.cir.0000048894.99865.02 · Cited by 1,084
Self-citationMatrix Metalloproteinases and Cardiovascular Disease
Dollery, C. M., McEwan, J. R., & Henney, A. M. (1995) · Circulation Research · doi:10.1161/01.res.77.5.863 · Cited by 864
Newby, A. C. (2005) · Physiological Reviews · doi:10.1152/physrev.00048.2003 · Cited by 817
Zhang, B., Ye, S., Herrmann, S.-M., Eriksson, P., de Maat, M., Evans, A., Arveiler, D., Luc, G., Cambien, F., Hamsten, A., et al. (1999) · Circulation · doi:10.1161/01.cir.99.14.1788 · Cited by 611
Metadata
- Authors
- Pauly, R. R., Passaniti, A., Bilato, C., Monticone, R., Cheng, L., Papadopoulos, N., Gluzband, Y. A., Smith, L., Weinstein, C., & Lakatta, E. G.
- Venue
- Circulation Research
- Published
- 1994-07
- Volume
- 75
- Issue
- 1
- Pages
- 41-54
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- OpenAlex
- W2150682250
- Cited by
- 313
- References
- 42
- FWCI
- 6.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.